UNSPSC 51332301: Axamozide
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51332300
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51332301
Definition
This classification denotes an antipsychotic agent with the molecular formula C21H22ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MCG9O55T6K, chemically known as ( -)-1-(1-(1,4-benzodioxan-2-ylmethyl)-4-piperidyl)-5-chloro-2-benzimidazolinone but generally known as axamozide, which bears US NIH Compound Identifier 170359. European Medicines Agency schedules Axamozide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05621MIG.
Read the full definition
The term AXAMOZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). AXAMOZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule axamozide under HS 29349990 and SITC 51579. As of Q4 2014, AXAMOZIDE remains the US FDA Preferred Term for this commodity. Axamozide bears US NLM identifiers UMLS ID C2346888 and NCI Concept Code C73281. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CC3OC4C(OC3)CCCC4)C2CC1.
About UNSPSC 51332301
UNSPSC 51332301 Axamozide is a Commodity code that in recent state and local procurement reflects purchasing of naloxone and drug deactivation systems for community health and emergency response support. The scope of work under this code centers on the procurement of pharmaceutical countermeasure products and related harm-reduction equipment intended for public health delivery, with vendors responsible for packaging, shipping, and quarterly delivery logistics to designated facilities. Issuing bodies soliciting under this code include county government health departments and community health programs, which coordinate procurement through competitive bidding to support substance-use response and public safety initiatives.
Seminole County, Florida issued IFB 60459723LAS in June 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, at 2:00 pm. The contract spans an initial two-year term with an optional one-year renewal and requires vendors to meet E-Verify compliance, maintain commercial general liability and workers' compensation insurance, and comply with federal regulations including the Clean Air Act and Federal Water Pollution Control Act when FEMA funding applies. Quarterly deliveries are directed to Seminole County Community Health Building in Sanford, Florida, with all shipping costs included in the vendor's proposal pricing. Recent activity under this code shows limited volume with a single identified opportunity in Florida; the code does not display broad geographic distribution or heavy state and local procurement activity at this time.
Quick answers
What is UNSPSC 51332301?
UNSPSC 51332301 is Axamozide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51332301?
UNSPSC 51332301 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51332301
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code